Sequenom, Inc. (NASDAQ: SQNM) has priced its public secondary offering of 5,500,000 shares of common stock at a price of $15.50 per share, and underwriters have a 30-day option to purchase up to an…
StemCells Inc. (NASDAQ: STEM) has filed a mixed securities shelf registration that will allow the company to raise up to $100 million in securities sales via any combination of stock, debt, preferred stock, and…
One key stock to watch next week is Pfizer Inc. (NYSE: PFE). While it has been in the land of the boring forever, watchers are looking to see if it will put in a…
An Australian company called Peplin Inc., which originally filed to come public in August 2007, has filed with the SEC to withdraw its IPO paperwork. The emerging biotech was going to carry the "PLIN"…
Out of the daily movers this last week, many of the top winners and losers were from news in many of the smaller biotech stocks. We prepared a list of the winners and sinners…
A company called Acclarent, Inc. has filed to come public via an IPO of up to $86.25 million in common stock. The company hasn’t selected an exchange or ticker, but noted that it will…
Boston Scientific Corporation (NYSE: BSX) is making a move which may be a questionable one if you have followed this stock for a while. The company said that President and CEO Jim Tobin will…
Capital Senior Living Corp. (NYSE:CSU) has announced that a Special Committee of its Board of Directors has engaged Banc of America Securities, part of Bank of America (NYSE: BAC), as its financial advisor. …
It looks like Pfizer’s (PFE) anti-smoking drug Chantix makes people kick the habit but at the same time can push them toward suicide or depression. It is a hard decision whether patients want to…
Nanotechnology is one of those industries that has advocates lining up for it and against it. The theoretical possibilities are endless. These could be in micro-computing, arterial plaque attacks, tissue repair, cleaning surfaces, cancer…
Satyam Computer Services Ltd. (NYSE: SAY) has partnered with General Electric Co. (NYSE: GE) unit GE Healthcare to support customers deploying healthcare IT solutions based on GE Centricity Enterprise software. The companies will jointly…
Shares of Amgen Inc. (NASDAQ: AMGN) are seeing a small gain in after-hours trading. The troubled biotech giant announced that findings from its head-to-head, double-blind trial comparing the effects of denosumab in post-menopausal women…
Carl Icahn is a billionaire financier, activist, and investor. Most think of Icahn as an activist investor that wants to get inside and drive value without having to acquire the whole company to resell…
Pharmacopeia, Inc. (NASDAQ: PCOP) is seeing shares surge in pre-market and at the open of trading today. The company said that PS433540, its first-in-class Dual Acting Receptor Antagonist, showed statistically significant blood pressure reductions…
Last night was a novel release from the American Society of Clinical Oncology (or ASCO) as the society decided to publish all of the findings to the public at once. Keep in mind that…